Search Results 1231-1240 of 10582 for total t4

1. General Internal Medicine - Clinical trials

   Explore services for a healthy lifestyle, early disease detection, preventive strategies and diagnosis of adults with unexplained symptoms.

2. A Study To Compare Standard Therapy To Treat Hodgkin Lymphoma To The Use Of Two Drugs, Brentuximab Vedotin And Nivolumab - Mayo Clinic

   Total bilirubin =< 2 x upper limit of normal (ULN) (within 7 days prior to enrollment). Unless due to Gilbert's disease, lymphomatous involvement of liver or ...

3. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 × upper limit of normal (ULN) or ≤ 3xULN with documented Gilbert's syndrome;; Aspartate aminotransferase (AST) and alanine ...

4. Ablation therapy - Mayo Clinic

   Healthcare providers that perform ablation therapy may include doctors trained in imaging, called radiologists, heart specialists called cardiologists, and ...

5. Gastroenterology and Hepatology - Clinical trials

   ... overall histopathological reading and no worsening of liver fibrosis on NASH Clinical Research Network (CRN) fibrosis score. Resolution of NASH is defined ...

6. Treatment of Pain Associated with Fibromyalgia - Mayo Clinic

   Participation eligibility · Age ≥ 18 years · Able to give written informed consent · Able to complete subject-reported questionnaires per the investigator's ...

7. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

   Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) AND aspartate transaminase (AST) ≤ 1.5 x ULN;; PT/INR/aPTT ≤ 1.5 x ULN; OR if patient is ...

8. A Study to Determine the Effectiveness of Early Intensive vs. Escalation Approach to Treat Relapsing/Remitting Multiple Sclerosis - Mayo Clinic

   ... whole brain volume loss measured using MRI in PwRRMS from Baseline to Month 36. Multi-center pragmatic comparative effectiveness randomized clinical trial ...

9. A Study To Test The Addition Of The Drug Cabozantinib To Chemotherapy In Patients With Newly Diagnosed Osteosarcoma - Mayo Clinic

   Note: Estimated GFR (eGFR) from serum creatinine, cystatin C or other estimates are not acceptable for determining eligibility. Total bilirubin =< 1.5 x ...

10. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

    Adequate renal and liver function as indicated by serum creatinine ≤ 1.0 x ULN or creatinine clearance of > 60 cc/min, serum albumin ≥ 3.0 gm/dL, total ...